Trials in progress: A phase I study to evaluate the safety and pharmacokinetic profiles of CB-5339 in participants with relapsed/refractory acute myeloid leukemia or relapsed/refractory intermediate or high-risk myelodysplastic syndrome Meeting Abstract
| Authors: | Benajiba, L.; Carraway, H. E.; Hamad, N.; Stein, E. M.; Yannakou, C. K.; Burroughs, A.; Harris, S.; Lane, H.; Nguyen, D. D.; Stuart, M.; Vargas, J.; Puissant, A.; Stegmaier, K.; DiNardo, C. D. |
| Abstract Title: | Trials in progress: A phase I study to evaluate the safety and pharmacokinetic profiles of CB-5339 in participants with relapsed/refractory acute myeloid leukemia or relapsed/refractory intermediate or high-risk myelodysplastic syndrome |
| Meeting Title: | 62nd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 136 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2020 Dec 5-8 |
| Meeting Location: | Virtual |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2020-11-05 |
| Language: | English |
| DOI: | 10.1182/blood-2020-140636 |
| PROVIDER: | manual |
| Notes: | Meeting Abstract: 21 |
